Hsbc Holdings PLC Regenxbio Inc. Transaction History

Hsbc Holdings PLC

$159 Billion
Q1 2025

A detailed history of Hsbc Holdings PLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 55,815 shares of RGNX stock, worth $466,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,815

Previous 84,817 34.19%

Holding current value

$466,613

Previous $655,000 39.08%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$5.92 - $8.7 $171,691 - $252,317	-29,002 Reduced 34.19%	55,815 $399,000
Q4 2024 Feb 14, 2025	BUY	$7.23 - $11.56 $349,281 - $558,463	48,310 Added 132.33%	84,817 $655,000
Q3 2024 Nov 14, 2024	BUY	$10.49 - $14.39 $174,039 - $238,744	16,591 Added 83.3%	36,507 $382,000
Q2 2024 Aug 12, 2024	BUY	$11.51 - $21.53 $62,027 - $116,025	5,389 Added 37.1%	19,916 $233,000
Q1 2024 May 15, 2024	SELL	$12.17 - $24.61 $165,731 - $335,138	-13,618 Reduced 48.39%	14,527 $306,000
Q4 2023 Feb 12, 2024	SELL	$12.89 - $20.82 $31,412 - $50,738	-2,437 Reduced 7.97%	28,145 $505,000
Q3 2023 Nov 13, 2023	SELL	$16.46 - $19.99 $113,392 - $137,711	-6,889 Reduced 18.38%	30,582 $503,000
Q2 2023 Aug 11, 2023	BUY	$17.23 - $21.71 $110,116 - $138,748	6,391 Added 20.56%	37,471 $749,000
Q1 2023 May 15, 2023	BUY	$18.08 - $24.55 $263,696 - $358,061	14,585 Added 88.42%	31,080 $587,000
Q4 2022 Feb 14, 2023	BUY	$20.4 - $24.73 $87,230 - $105,745	4,276 Added 34.99%	16,495 $374,000
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $84,991 - $133,607	3,813 Added 45.36%	12,219 $328,000
Q2 2022 Aug 11, 2022	SELL	$19.35 - $35.04 $21,807 - $39,490	-1,127 Reduced 11.82%	8,406 $210,000
Q1 2022 May 16, 2022	BUY	$24.62 - $34.31 $234,702 - $327,077	9,533 New	9,533 $321,000
Q3 2021 Nov 12, 2021	SELL	$29.09 - $45.68 $226,552 - $355,755	-7,788 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$32.46 - $40.48 $203,686 - $254,011	-6,275 Reduced 44.62%	7,788 $302,000
Q1 2021 May 14, 2021	BUY	$33.61 - $49.95 $472,657 - $702,446	14,063 New	14,063 $479,000
Q3 2020 Nov 12, 2020	SELL	$27.01 - $40.26 $1.2 Million - $1.79 Million	-44,578 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.75 - $43.44 $1.24 Million - $1.94 Million	44,578 New	44,578 $1.64 Million
Q1 2020 May 15, 2020	SELL	$21.5 - $54.2 $113,584 - $286,338	-5,283 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$34.54 - $44.87 $60,030 - $77,984	-1,738 Reduced 24.75%	5,283 $217,000
Q3 2019 Nov 14, 2019	BUY	$31.84 - $50.88 $28,114 - $44,927	883 Added 14.39%	7,021 $250,000
Q2 2019 Aug 13, 2019	BUY	$42.0 - $59.29 $34,818 - $49,151	829 Added 15.61%	6,138 $316,000
Q1 2019 May 15, 2019	BUY	$40.82 - $62.45 $216,713 - $331,547	5,309 New	5,309 $304,000

Others Institutions Holding RGNX

# of Institutions

182

Shares Held

45.4M

Call Options Held

64.9K

Put Options Held

103K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $361M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Regenxbio Inc. Transaction History